CCR4 and plasma cell myeloma: To study the expressions of C-C class chemokine 17(CCL17), C-C class chemokine 22(CCL22), and C-C chemokine receptor 4(CCR4)in newly diagnosed multiple myeloma(NDMM)for analyzing their correlations with clinical features and to preliminarily explore their roles in the development of NDMM.